Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03527290
Other study ID # 2017-3929
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2018
Est. completion date November 5, 2020

Study information

Verified date March 2021
Source University of California, Irvine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study aims to recruit 30 adults with abdominal obesity, without major chronic disease, and test whether clinical dietary advice that is solely focused on the timing of eating (time restricted eating), has an effect on cardiometabolic health compared to standard dietary advice for cardiometabolic health, which is focused on content. The goal of this pilot study is to develop and hone dietary counseling approaches for time restricted eating for RD's in a clinical practice paradigm, and collect data on testing this intervention compared to standard dietary counseling approaches for cardiometabolic health.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date November 5, 2020
Est. primary completion date July 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years to 75 Years
Eligibility Inclusion Criteria: - Abdominal obesity (waist circumference =35" for women and =40" for men; if Asian ethnicity, =35" for men and =31.5" for women) - weight stable over the previous 2 months - medications stable for > 3 months - self-reported 24-hr sleep-wake patterns within the appropriate range as defined by the National Sleep Foundation (self-reported habitual sleep duration 6-10 hours during nocturnal hours) - regular meal patterns - from the greater UCI and Orange county area - willing to incorporate a dietary approach aimed at improving cardiometabolic health and weight management - able to speak, read and understand English or Spanish Exclusion Criteria: - Self-reported unstable hypertension - Type 1 or 2 diabetes mellitus - heart, renal, or liver disease - cancer or active neoplasms - hyperthyroidism unless treated and under control - taking any medications known to affect clinical risk measures of interest or weight/energy expenditure (except for stable blood pressure medication) - active usual smoking (tobacco or marijuana) - alcohol intake > 3 drinks/day - pregnancy, current lactation, or plans to become pregnant during the study

Study Design


Intervention

Behavioral:
Time Restricted Eating
The intervention is delivered in a paradigm in which an individual with abdominal obesity would be referred by their physician to receive dietary counseling from a Registered Dietitian (RD). The aim of the intervention is to improve cardiometabolic health and assist with weight management via 4, individualized counseling sessions over the course of 8 weeks. Participants are educated on basic concepts related to circadian rhythms, metabolism and TRE; and the evidence demonstrating benefit of TRE in animal models and humans. The goal is provide rationale for the potential benefits of a TRE approach. In addition, the RD sessions focus on developing a plan for successfully implementing a TRE approach, identifying challenges for adherence, and a plan for dealing with real or potential challenges. The counseling is focused the TRE concept, with no specific direction or counseling related to modifying the content of the participant's diet or any prescription to reduce energy intake.
Standard Cardiometabolic Health Diet
The intervention is delivered in a paradigm in which an individual with abdominal obesity would be referred by their physician to receive dietary counseling from a Registered Dietitian (RD). The aim of the intervention is to improve cardiometabolic health and assist with weight management via 4, individualized counseling sessions over the course of 8 weeks. Participants are educated on basic concepts and known benefits related to eating a diet for cardiometabolic health and weight management recommended by the American Heart Association and the Academy of Nutrition and Dietetics as a standard of practice for dietitians in healthcare settings. The RD sessions focus on adopting a dietary pattern aligned with this approach, identifying challenges to adopting this dietary pattern, and education and plans for dealing with real or potential challenges. The counseling gives no direction related to modifying the timing of dietary intake or any prescription to reduce energy intake.

Locations

Country Name City State
United States Institute for Clinical and Translational Science Irvine California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Eating duration Glycemic data from blinded continuous glucose monitor to estimate actual daily eating period Run-in (up to 2 weeks), Intervention (8 weeks)
Primary Triglyceride : HDL cholesterol ratio Ratio of fasting triglycerides to HDL cholesterol 8 weeks
Secondary HOMA-IR Estimation of HOMA-IR from fasting glucose and insulin 8 weeks
Secondary Glucose Fasting glucose 8 weeks
Secondary Insulin Fasting insulin 8 weeks
Secondary LDL cholesterol LDL cholesterol 8 weeks
Secondary Weight Body weight measured on calibrated scale 8 weeks
Secondary Waist Circumference Measured by standard approach utilized in NHANES 8 weeks
Secondary Diet Quality Assessed by 2 unannounced recalls during run-in period and 3 during intervention Run-in (up to 2 weeks), Intervention (8 weeks)
Secondary Post-hoc estimated energy intake Estimated by utilizing NIDDK Body weight planner with weights measured over 8 weeks 8 weeks
Secondary Objective sleep and physical activity habits Measured with fitbit Run-in (up to 2 weeks), Intervention (8 weeks)
Secondary Blood pressure Resting systolic and diastolic blood pressure 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT03142633 - MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03383822 - Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT04203238 - Potato Research for Enhancing Metabolic Outcomes N/A
Recruiting NCT03658564 - Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance N/A
Completed NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics Phase 4
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03627104 - Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A
Active, not recruiting NCT03288025 - Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE) N/A
Completed NCT03809182 - Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels. Phase 4
Completed NCT01809288 - Identifying Risk for Diabetes and Heart Disease in Women
Completed NCT04642482 - Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity Phase 4
Terminated NCT03278236 - Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Withdrawn NCT04741204 - Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer Phase 4
Not yet recruiting NCT05540249 - Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG N/A